National Cancer Institute
Found 10 results for your search:
Total relevant funding to Down Syndrome for this search:
$1,423,795
Fiscal Year FY 2016
Research Topic [Down Syndrome]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 10 of 10 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites 3R01CA118374-08S1 $52,451 $26,226 RYEOM, SANDRA UNIVERSITY OF PENNSYLVANIA
2
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites 5R01CA118374-08 $342,000 $171,000 RYEOM, SANDRA UNIVERSITY OF PENNSYLVANIA
3
Collaborative Perinatal Project ZIA CP010126-01048 $301 $60 McGlynn, Katherine DCEG (NCI)
4
CRLF2 signaling in B-cell acute lymphoblastic leukemia 2R01CA151898-06A1 $392,969 $196,485 WEINSTOCK, DAVID DANA-FARBER CANCER INST
5
CRLF2 signaling in B-cell acute lymphoblastic leukemia 3R01CA151898-06A1S1 $199,999 $100,000 WEINSTOCK, DAVID DANA-FARBER CANCER INST
6
DYRK1A signaling in control of cell growth, proliferation and DNA damage repair 5R01CA188571-02 $341,494 $341,494 LITOVCHICK, LARISA VIRGINIA COMMONWEALTH UNIVERSITY
7
Mechanisms of Leukemogenesis in Down Syndrome 4R01CA101774-14 $303,965 $303,965 CRISPINO, JOHN NORTHWESTERN UNIVERSITY AT CHICAGO
8
Polysomy 21 in Acute Lymphoblastic Leukemia 4R01CA172387-04 $352,946 $176,473 WEINSTOCK, DAVID DANA-FARBER CANCER INST
9
Targeting Chromatin Modifications in Leukemia with Trisomy 21 5K08CA181340-03 $155,991 $77,996 LANE, ANDREW DANA-FARBER CANCER INST
10
The Role of Trisomy 21 in Hematopoiesis and Leukemogenesis 5F31CA196231-02 $30,096 $30,096 LIGGETT, LUTHER UNIVERSITY OF COLORADO DENVER
Total relevant funding to Down Syndrome for this search: $1,423,795
Showing 1 - 10 of 10 results
Go to top